The Alzheimer's Enigma
mosaicscience.com
mosaicscience.com
1. http://opinionator.blogs.nytimes.com/2012/09/25/bittman-is-a...
More likely there are contributions from multifactorial elements: some propensity to form Amyloid plaques (from APP mutations or downstream processing mutations), some contribution from tau; there is a significant body of evidence to show that APOE3 carriers (cholesterol transport proteins) have a higher risk (something particularly relevant for myself given I am an APOE3 heterozygote) and the more recent 'type 3 diabetes' studies, which seem promising however the way they are bandied around by the 'sugar is evil' crowd my gut feeling is that they push the line a bit more vehemently then the evidence would suggest at present
In my experience, when the body is in a good state of healthy balance, there is little appetite for refined sugars, carbs, and all the other usual culprits of the anti-sugar set.
Such a body can happily tolerate some indulgence - eg, a night or two per week having sugary desserts and cocktails.
But after a certain amount of indulgence, the body responds by feeling bad (hangovers, brain fog etc), and the this healthy person heeds the signal to ease off for a few days.
However there's a significant proportion of the population for whom the body isn't in a state of healthy balance, which causes them to have too great an appetite for sugar, which leads to exacerbated health problems (diabetes, heart disease, Alzheimer's, etc).
All my research and experience leads me to believe that excess sugar consumption is more of a symptom than a primary cause.
http://www.helpguide.org/elder/alzheimers_prevention_slowing...
1. https://en.wikipedia.org/wiki/Alzheimer%27s_disease#Other_hy...
Unfortunately, I think it is more accurate to say they are not longer the same person.
More generally, while this article mostly discusses treatment, the physical symptoms of plaques, tangles, and neural degeneration occur before a patient starts displaying dementia. Assuming an Alzheimer's treatment can't reverse the damage done, it would have to be coupled with an early diagnostic, something which doesn't exist yet.
1. http://en.wikipedia.org/wiki/Olfactory_receptor_neuron#media...
2. http://www.nature.com/ncomms/journal/v3/n8/fig_tab/ncomms201...
I'm actually starting a PhD in a group that's hoping to use imaging (e.g. ASL/DCMRI) for just this purpose! Very early days in this, both for me and the group, but there are a lot of different things that can be tried.
It's a growing 'epidemic', though strangely due to improvements in medicine: we're living longer. Best of luck.
I prefer to draw a comparison to CS. The Tau vs Amyloid camps are essentially defining two spaces where potential solutions may exist. It seems like the research is doing brute-force depth-first searches across potential solution spaces. Viewed in this manner, and given the lack of results, I wonder if a more comprehensive (breadth-first) approach might be more appropriate. Accounting for all sides of the puzzle rather than focusing on only one.
Undoubtedly more funding will be required in any case.
Scanning the comments: No one really thinks that Tau is responsible anymore. The problem is that we only rather recently realized soluble AB oligomers are the most distal causative agent. T3 diabetes is again a distal effect of the etiologic agent of AD; what causes T3 diabetes?
I would encourage anyone who is interested to begin with this paper: http://www.cell.com/abstract/S0092-8674(13)00387-5 (Zhang et al. Cell 2013).
What is often overlooked in the study of Alzheimer's disease is the APOE gene. This comes as three forms, each differing from the other by only a few amino acids. These are called APOE2, APOE3 and APOE4. The most common form is APOE3, APOE2 and APOE4 are each present in about 6-10% of people (heterozygous).
People who are homozygous for the APOE2 form almost never get Alzheimer's disease, whereas those who have the APOE4 form have a more than 50% chance of getting Alzheimer's disease before they die.
So... there must be a link between the APOE gene and tau... since both are the strongest correlates with the disease, in pathology and genetics, respectively.
However, you would be hard pressed to find a study that demonstrated a mechanistic link between these two factors (apart from Alzheimer's disease, of course).
As a researcher in the field, I think this is one of the most intriguing aspects.
Link to open access review on APOE in Alzheimer's disease:
http://dx.doi.org/10.1016/j.neuron.2012.11.020
Edit: For those interested in a reputable collection of recent reviews on the biology of Alzheimer's disease:
http://perspectivesinmedicine.cshlp.org/cgi/collection/the_b...
* http://snpedia.com/index.php/Rs429358
* http://snpedia.com/index.php/Rs7412
is low, but not low enough to justify the near total absence of E1/E1.
ApoE1 is simply rare, and not really relevant to Alzheimer's disease, although it does affect blood cholesterol levels.
The apoE1 snp is Rs121918394
Crude example, should we focus on finding cures for consequences of lead poisoning, instead removing the cause: lead in paint, cosmetics, fuels...
Human breast milk provides a lot of cholesterol. Not only that, mother’s milk provides a specific enzyme to allow the baby’s digestive tract to absorb almost 100 percent of that cholesterol, because the developing brain and eyes of an infant require large amounts of it. Children deprived of cholesterol in infancy may end up with poor eyesight and brain function. Manufacturers of infant formulas are aware of this fact, but following the anti-cholesterol dogma, they produce formulas with virtually no cholesterol in them.
One of the most abundant materials in the brain and the rest of our nervous system is a fatty substance called myelin. Myelin coats every nerve cell and every nerve fiber like the insulating cover around electric wires. Apart from insulation, it provides nourishment and protection for every tiny structure in our brain and the rest of the nervous system. People who start losing their myelin develop a condition called multiple sclerosis. Well, 20 percent of myelin is cholesterol. If you start interfering with the body’s ability to produce cholesterol, you put the very structure of the brain and the rest of the nervous system under threat.
Now, think about statins
Genetic Predisposition to Increased Blood Cholesterol and Triglyceride Lipid Levels and Risk of Alzheimer Disease: A Mendelian Randomization Analysis. 10.1371/journal.pmed.1001713